{"id":2920,"date":"2016-11-11T20:07:06","date_gmt":"2016-11-11T20:07:06","guid":{"rendered":"http:\/\/www.medicalmarijuanainc.com\/?p=18345"},"modified":"2016-11-11T20:07:06","modified_gmt":"2016-11-11T20:07:06","slug":"big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap","status":"publish","type":"post","link":"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/","title":{"rendered":"Why Big Pharma is Scared of Cannabinoids \u2013 and How Medical Marijuana, Inc. is Bridging the Gap"},"content":{"rendered":"

[vc_row][vc_column][vc_column_text]As cannabis continues to expand into a multi-billion dollar international market, other sectors of the economy are beginning to feel the effects of this new industry\u2019s growth \u2013 none more so than pharmaceuticals. This raises an important question: can marijuana and the pharmaceutical industry co-exist?<\/span><\/p>\n

The Big Pharma Question<\/strong><\/h3>\n

Big Pharma is currently losing potential profit in states that have already legalized medical marijuana. <\/span>Research<\/span><\/a> from the University of Georgia shows that prescription medication use is down in states with established medical marijuana programs. The average doctor in these states prescribed 265 fewer doses of antidepressants each year of the study, 486 fewer doses of seizure medication, 541 fewer anti-nausea doses, and 562 fewer doses of anti-anxiety medication. However, it was pain medication that was hardest hit, seeing an average of 1,826 fewer doses in medical marijuana states. <\/span><\/p>\n

The researchers in the study wanted to determine just how much revenue the pharmaceutical industry has lost in medical marijuana states. In 2013, the 17 states with medical marijuana laws saved an estimated $165 million on prescription pills. Extrapolating from their findings, the team concluded that, if medical cannabis was legalized at the federal level, over $500 million would vanish from the pharmaceutical industry\u2019s annual revenue reports.<\/span><\/p>\n

Big Pharma has not taken this challenge to their bottom line lightly. While many pharmaceutical companies have openly lobbied against cannabis legalization, others have gone further and donated large sums to fight legalization. Insys Therapeutics, Inc., the makers of fentanyl, donated $500,000 to Arizonans for Responsible Drug Policy, an anti-cannabis group, to successfully oppose legalization in Arizona in 2016. Fentanyl, touted to be 50 times more potent than morphine, is best known for contributing to Prince\u2019s overdose death. With the potential loss of revenue from marijuana, companies like Insys have a vested interest in preventing marijuana from becoming legal. <\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_single_image image=”17843″ img_size=”1200×250″ onclick=”custom_link” link=”https:\/\/www.medicalmarijuanainc.com\/medical-marijuana-can-curb-opioid-use-study-indicates\/”][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]However, it is possible to create new prescription drugs for these conditions using cannabinoids without interfering with cannabis\u2019s path to legalization. Two of Medical Marijuana, Inc.\u2019s investment companies are currently developing novel treatments using hemp-based cannabinoids like CBD, while Medical Marijuana, Inc. itself supported California\u2019s successful legalization effort with a donation, proving the relationship between marijuana and pharmaceuticals doesn\u2019t need to be contentious. <\/span><\/p>\n

Few companies though have the resources necessary to develop cannabis-based treatments by working directly with the DEA, which requires costly fees and intensive oversight of the testing and development process. <\/span><\/p>\n

AXIM\u00ae Biotechnologies<\/strong><\/h3>\n

AXIM\u00ae Biotechnologies, a Medical Marijuana, Inc. investment company, just recently received the funding needed to pursue multiple clinical trials on cannabinoid derived drugs. <\/span><\/p>\n

The company\u2019s cannabinoid-infused chewing gum MedChew\u00ae RX is being prepared for trials for the pain and spasticity associated with multiple sclerosis. The study is scheduled to take 12 months and should be followed by FDA\/EMA registration as a novel treatment for MS. <\/span><\/p>\n

AXIM\u00ae is also running clinical trials on its CanChew\u00ae Plus cannabinoid chewing gum to determine the formulation\u2019s potential as a treatment for Irritable Bowel Syndrome (IBS). The study will test two different potencies of CanChew\u00ae gum to choose the ideal dosing for the next phase of trials. <\/span><\/p>\n

Finally, AXIM\u00ae Biotechnologies is pursuing clinical studies on its proprietary topical cannabinoid application, AX-1602. AXIM\u00ae plans to test AX-1602 for the treatment of psoriasis and eczema. The company\u2019s patent pending topical is made using cannabigerol or CBG, known as the \u201cstem cell cannabinoid\u201d for its ability to become any other cannabinoid. <\/span><\/p>\n

Kannalife\u2122 Sciences<\/strong><\/h3>\n

Another of Medical Marijuana, Inc.\u2019s investment companies, Kannalife\u2122 Sciences is also working to develop novel new treatments derived from cannabinoids. Using their licenses on the government\u2019s patent 6,630,507, Cannabinoids as antioxidants and neuroprotectants, Kannalife\u2122 Sciences is developing new cannabinoid-based medications for a pair of degenerative brain conditions, hepatic encephalopathy and chronic traumatic encephalopathy. <\/span><\/p>\n

Hepatic encephalopathy (HE) results when the liver cannot function properly, allowing toxins to reach the brain and damaging functionality. HE typically occurs in those with chronic liver disease. Chronic traumatic encephalopathy is the result of repeated blows to the head. Linked to concussions, CTE is estimated to affect over <\/span>90% of NFL players<\/span><\/a>, but may be found in anyone with head injuries. <\/span><\/p>\n

Although Kannalife\u2122 Sciences is focusing on these two conditions in their research now, the company\u2019s work can open up treatments for a number of other neurodegenerative diseases, like Alzheimer\u2019s disease and Parkinson\u2019s disease. <\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_single_image image=”17365″ img_size=”1200×250″ onclick=”custom_link” link=”https:\/\/www.medicalmarijuanainc.com\/overview-of-medical-marijuana-research\/”][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n

The Future of Cannabis Medicines<\/strong><\/h3>\n

Although the DEA recently rejected requests to reschedule cannabis out of Schedule I, the classification saved for the most dangerous drugs, the agency\u2019s new policies have opened the door for increased research into the plant to examine its medicinal potential. <\/span><\/p>\n

It will be this medical research that eventually solidifies the pathway of further cannabis-based drugs to FDA approval. It is unlikely that the FDA will ever endorse smokeable or edible whole plant marijuana as medicine, and instead, pharmaceutical companies will have to follow the traditional path to new drug designation, including intense clinical research to prove safety and efficacy. <\/span><\/p>\n

The FDA has already approved cannabis-based drugs in the past. Once approved, the drug itself is then classified separately from whole plant marijuana. For example, Marinol, a synthetic THC medication, is classified as a Schedule III drug, and is available by prescription for cancer and AIDS patients.<\/span><\/p>\n

Looking toward a future pharmaceutical market that includes cannabinoid-based medications, Medical Marijuana, Inc. and its investment companies are actively pursuing the medical research, new drug development, and clinical trials that will be necessary to establish cannabis as an FDA approved medicine. <\/span><\/p>\n

For more news on these and other Medical Marijuana, Inc. investments, <\/span>follow our news feed<\/span><\/a>. <\/span>[\/vc_column_text][\/vc_column][\/vc_row] \t<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_column_text]As cannabis continues to expand into a multi-billion dollar international market, other sectors of the economy are beginning to feel the effects of this new industry\u2019s growth \u2013 none more so than pharmaceuticals. This raises an important question: can marijuana and the pharmaceutical industry co-exist? The Big Pharma Question Big Pharma is currently losing potential […]<\/p>\n","protected":false},"author":1,"featured_media":2921,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[160,3,185,163],"tags":[],"class_list":["post-2920","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-axim-biotechnologies","category-company-news","category-industry-updates","category-kannalife-sciences"],"yoast_head":"\nWhy Big Pharma is Scared of Cannabinoids \u2013 and How Medical Marijuana, Inc. is Bridging the Gap - Medical Marijuana, Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Why Big Pharma is Scared of Cannabinoids \u2013 and How Medical Marijuana, Inc. is Bridging the Gap - Medical Marijuana, Inc.\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_column_text]As cannabis continues to expand into a multi-billion dollar international market, other sectors of the economy are beginning to feel the effects of this new industry\u2019s growth \u2013 none more so than pharmaceuticals. This raises an important question: can marijuana and the pharmaceutical industry co-exist? The Big Pharma Question Big Pharma is currently losing potential […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/\" \/>\n<meta property=\"og:site_name\" content=\"Medical Marijuana, Inc.\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/MJNAInc\" \/>\n<meta property=\"article:published_time\" content=\"2016-11-11T20:07:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2016\/11\/mjna-blog-images-working-lab-11-09-16-ver1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"adminTorusBrand\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@mjna_inc\" \/>\n<meta name=\"twitter:site\" content=\"@mjna_inc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminTorusBrand\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/\"},\"author\":{\"name\":\"adminTorusBrand\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c\"},\"headline\":\"Why Big Pharma is Scared of Cannabinoids \u2013 and How Medical Marijuana, Inc. is Bridging the Gap\",\"datePublished\":\"2016-11-11T20:07:06+00:00\",\"dateModified\":\"2016-11-11T20:07:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/\"},\"wordCount\":1026,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\"},\"articleSection\":[\"Axim Biotechnologies\",\"Company News\",\"Industry Updates\",\"Kannalife Sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/\",\"url\":\"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/\",\"name\":\"Why Big Pharma is Scared of Cannabinoids \u2013 and How Medical Marijuana, Inc. is Bridging the Gap - Medical Marijuana, Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#website\"},\"datePublished\":\"2016-11-11T20:07:06+00:00\",\"dateModified\":\"2016-11-11T20:07:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/medicalmarijuanainc.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Why Big Pharma is Scared of Cannabinoids \u2013 and How Medical Marijuana, Inc. is Bridging the Gap\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#website\",\"url\":\"https:\/\/medicalmarijuanainc.com\/\",\"name\":\"Medical Marijuana, Inc.\",\"description\":\"We are a company of firsts\u00ae\ufe0f. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. Through its subsidiaries, Medical Marijuana, Inc. manufacturers and sells some of the best cannabidiol (CBD), and other cannabinoid-based products, available!\",\"publisher\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/medicalmarijuanainc.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#organization\",\"name\":\"Medical Marijuana, Inc.\",\"url\":\"https:\/\/medicalmarijuanainc.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png\",\"contentUrl\":\"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png\",\"width\":512,\"height\":512,\"caption\":\"Medical Marijuana, Inc.\"},\"image\":{\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/MJNAInc\",\"https:\/\/twitter.com\/mjna_inc\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c\",\"name\":\"adminTorusBrand\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g\",\"caption\":\"adminTorusBrand\"},\"sameAs\":[\"https:\/\/medicalmarijuanainc.com\"],\"url\":\"https:\/\/medicalmarijuanainc.com\/author\/admintorusbrand\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Why Big Pharma is Scared of Cannabinoids \u2013 and How Medical Marijuana, Inc. is Bridging the Gap - Medical Marijuana, Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/","og_locale":"en_US","og_type":"article","og_title":"Why Big Pharma is Scared of Cannabinoids \u2013 and How Medical Marijuana, Inc. is Bridging the Gap - Medical Marijuana, Inc.","og_description":"[vc_row][vc_column][vc_column_text]As cannabis continues to expand into a multi-billion dollar international market, other sectors of the economy are beginning to feel the effects of this new industry\u2019s growth \u2013 none more so than pharmaceuticals. This raises an important question: can marijuana and the pharmaceutical industry co-exist? The Big Pharma Question Big Pharma is currently losing potential […]","og_url":"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/","og_site_name":"Medical Marijuana, Inc.","article_publisher":"https:\/\/www.facebook.com\/MJNAInc","article_published_time":"2016-11-11T20:07:06+00:00","og_image":[{"width":1200,"height":500,"url":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2016\/11\/mjna-blog-images-working-lab-11-09-16-ver1.png","type":"image\/png"}],"author":"adminTorusBrand","twitter_card":"summary_large_image","twitter_creator":"@mjna_inc","twitter_site":"@mjna_inc","twitter_misc":{"Written by":"adminTorusBrand","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/#article","isPartOf":{"@id":"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/"},"author":{"name":"adminTorusBrand","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c"},"headline":"Why Big Pharma is Scared of Cannabinoids \u2013 and How Medical Marijuana, Inc. is Bridging the Gap","datePublished":"2016-11-11T20:07:06+00:00","dateModified":"2016-11-11T20:07:06+00:00","mainEntityOfPage":{"@id":"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/"},"wordCount":1026,"commentCount":0,"publisher":{"@id":"https:\/\/medicalmarijuanainc.com\/#organization"},"articleSection":["Axim Biotechnologies","Company News","Industry Updates","Kannalife Sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/","url":"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/","name":"Why Big Pharma is Scared of Cannabinoids \u2013 and How Medical Marijuana, Inc. is Bridging the Gap - Medical Marijuana, Inc.","isPartOf":{"@id":"https:\/\/medicalmarijuanainc.com\/#website"},"datePublished":"2016-11-11T20:07:06+00:00","dateModified":"2016-11-11T20:07:06+00:00","breadcrumb":{"@id":"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/medicalmarijuanainc.com\/2016\/11\/11\/big-pharma-scared-cannabinoids-medical-marijuana-inc-bridging-gap\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medicalmarijuanainc.com\/"},{"@type":"ListItem","position":2,"name":"Why Big Pharma is Scared of Cannabinoids \u2013 and How Medical Marijuana, Inc. is Bridging the Gap"}]},{"@type":"WebSite","@id":"https:\/\/medicalmarijuanainc.com\/#website","url":"https:\/\/medicalmarijuanainc.com\/","name":"Medical Marijuana, Inc.","description":"We are a company of firsts\u00ae\ufe0f. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space. Through its subsidiaries, Medical Marijuana, Inc. manufacturers and sells some of the best cannabidiol (CBD), and other cannabinoid-based products, available!","publisher":{"@id":"https:\/\/medicalmarijuanainc.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medicalmarijuanainc.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/medicalmarijuanainc.com\/#organization","name":"Medical Marijuana, Inc.","url":"https:\/\/medicalmarijuanainc.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/","url":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png","contentUrl":"https:\/\/medicalmarijuanainc.com\/wp-content\/uploads\/2023\/02\/cropped-logo-medical-marijuana-inc.png","width":512,"height":512,"caption":"Medical Marijuana, Inc."},"image":{"@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/MJNAInc","https:\/\/twitter.com\/mjna_inc"]},{"@type":"Person","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/bd5fa0cf1483b68c6bd5c117e3d4242c","name":"adminTorusBrand","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medicalmarijuanainc.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a912c97701c52370233e20a0d17ab853?s=96&d=mm&r=g","caption":"adminTorusBrand"},"sameAs":["https:\/\/medicalmarijuanainc.com"],"url":"https:\/\/medicalmarijuanainc.com\/author\/admintorusbrand\/"}]}},"_links":{"self":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts\/2920","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/comments?post=2920"}],"version-history":[{"count":0,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/posts\/2920\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/media\/2921"}],"wp:attachment":[{"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/media?parent=2920"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/categories?post=2920"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicalmarijuanainc.com\/wp-json\/wp\/v2\/tags?post=2920"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}